MUDr. Tomáš Doležal, Ph.D.
Research specialist, Department of Pharmacology
correspondence Address:
Kamenice 753/5, 625 00 Brno
e‑mail: |
---|
Total number of publications: 17
2021
-
Health-related quality of life in women with autoimmune thyroid disease during pregnancy and postpartum: systematic review including 321,850 pregnancies
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, year: 2021, volume: 21, edition: 6, DOI
-
Smoking in women with chronic vaginal discomfort is not associated with decreased abundance of Lactobacillus spp. but promotes Mobiluncus and Gardnerella spp. overgrowth - secondary analysis of trial data including microbiome analysis
ČESKÁ GYNEKOLOGIE, year: 2021, volume: 86, edition: 1, DOI
2020
-
Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390 Patients
Cancers, year: 2020, volume: 12, edition: 4, DOI
-
Short-term response in new users of anti-TNF predicts long-term productivity and non-disability: analysis of Czech ATTRA ankylosing spondylitis biologic registry
Expert Opinion on Biological Therapy, year: 2020, volume: 20, edition: 2, DOI
2019
-
Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS
MULTIPLE SCLEROSIS AND RELATED DISORDERS, year: 2019, volume: 35, edition: OCT 2019, DOI
-
Propensity Score Weighting Using Overlap Weights: A New Method Applied to Regorafenib Clinical Data and a Cost-Effectiveness Analysis
Value in health, year: 2019, volume: 22, edition: 12, DOI
2014
-
Health-economic aspects of cystic fibrosis screening and therapy
, edition: Vyd. 2014, year: 2014